RhinoCyte

Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of RhinoCyte plus 5234 other startups.

Start Free 7 Day Trial Now

Learn More About RhinoCyte

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients